FK-613

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameFK-613

Drug Alias NameFK 613FK-613

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistamine H1 receptor antagonistsSerotonin (5-HT) receptor antagonistsHistamine receptor antagonists

TargetsHistamine H1 receptorSerotonin (5-HT) receptorHistamine receptor

Therapy Area/IndicationsUrticariaRhinitis, AllergicAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsUrticariaRhinitis, AllergicAsthma

ATC CodeN/A